Literature DB >> 18681856

Expanding clinical spectrum of non-autoimmune hyperthyroidism due to an activating germline mutation, p.M453T, in the thyrotropin receptor gene.

Vichit Supornsilchai1, Taninee Sahakitrungruang, Nattakarn Wongjitrat, Suttipong Wacharasindhu, Kanya Suphapeetiporn, Vorasuk Shotelersuk.   

Abstract

OBJECTIVE: To describe clinical and genetic features of a Thai family with non-autoimmune hyperthyroidism (NAH) caused by an activating germline mutation in the thyrotropin receptor (TSHR) gene. PATIENTS: Three affected individuals from the same family (a father and his two children) were studied. Clinical and imaging findings were reviewed and compared. GENETIC ANALYSIS: Genomic DNA was extracted from peripheral blood leukocytes and mutation analysis of the entire coding sequence of the TSHR gene was performed in both children and their parents by direct DNA sequencing.
RESULTS: A heterozygous germline T to C transition in exon 10 of the TSHR gene (c.1358T-->C) resulting in the substitution of methionine (ATG) by threonine (ACG) at codon 453 (p.M453T) was identified in the father and his two children. They presented with different clinical severity and variable age of onset. In addition to hyperthyroidism, ventriculomegaly and bilateral shortening of the fifth metacarpal bones and the middle phalanges of the fifth fingers were consistently found in all affected individuals.
CONCLUSIONS: Ventriculomegaly and bilateral shortening of the fifth metacarpal bones and the middle phalanges of the fifth fingers might be characteristic features of NAH because of an activating TSHR germline mutation. In addition, the shortening of the middle phalanges of the fifth fingers has never been previously described, expanding the phenotypic spectrum of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18681856     DOI: 10.1111/j.1365-2265.2008.03367.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

1.  Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity.

Authors:  Eijun Nishihara; Chun-Rong Chen; Takuya Higashiyama; Yumiko Mizutori-Sasai; Mitsuru Ito; Sumihisa Kubota; Nobuyuki Amino; Akira Miyauchi; Basil Rapoport
Journal:  Thyroid       Date:  2010-10-07       Impact factor: 6.568

Review 2.  Thyroid hormone actions in cartilage and bone.

Authors:  Graham R Williams
Journal:  Eur Thyroid J       Date:  2012-12-19

3.  2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations.

Authors:  R Paschke; M Niedziela; B Vaidya; L Persani; B Rapoport; J Leclere
Journal:  Eur Thyroid J       Date:  2012-10-04

Review 4.  Hyperplasia in glands with hormone excess.

Authors:  Stephen J Marx
Journal:  Endocr Relat Cancer       Date:  2015-09-25       Impact factor: 5.678

Review 5.  Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.

Authors:  J H Duncan Bassett; Graham R Williams
Journal:  Endocr Rev       Date:  2016-02-10       Impact factor: 19.871

6.  A CASE OF FAMILIAL NONAUTOIMMUNE HYPERTHYROIDISM DURING PREGNANCY.

Authors:  Yuka Okazaki; Naoko Arata; Nagayoshi Umehara; Taisuke Yamauchi; Junnichi Tajiri; Akira Hishinuma; Takahiko Kogai; Takashi Idegami; Atsuko Murashima; Haruhiko Sago
Journal:  AACE Clin Case Rep       Date:  2020-01-22

7.  A new family with an activating mutation (G431S) in the TSH receptor gene: a phenotype discussion and review of the literature.

Authors:  Cæcilie C Larsen; Lefkothea P Karaviti; Victor Seghers; Roy E Weiss; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Int J Pediatr Endocrinol       Date:  2014-11-17

8.  Familial Non-autoimmune Hyperthyroidism in Family Members Across Four Generations Due To a Novel Disease-causing Variant in The Thyrotropin Receptor Gene.

Authors:  A Malej; M Avbelj Stefanija; N Bratanič; K Trebušak Podkrajšek
Journal:  Balkan J Med Genet       Date:  2021-03-23       Impact factor: 0.519

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.